Abstract
One of the major challenges in medicine today is the development of new antibiotics as well as effective antiviral agents. The well-known aminoglycosides interact and interfere with the function of several noncoding RNAs, among which ribosomal RNAs (rRNAs) are the best studied. Aminoglycosides are also known to interact with proteins such as ribonucleases. Here we review our current understanding of the interaction between aminoglycosides and RNA. Moreover, we discuss briefly mechanisms behind the inactivation of aminoglycosides, a major concern due to the increasing appearance of multiresistant bacterial strains. Taken together, the general knowledge about aminoglycoside and RNA interaction is of utmost importance in the process of identifying/developing the next generation or new classes of antibiotics. In this perspective, previously unrecognized as well as known noncoding RNAs, apart from rRNA, are promising targets to explore.
Chapter PDF
Similar content being viewed by others
References
Agnelli F, Sucheck SJ, Marby KA, Rabuka D, Yao S-L, Sears PS, Liang F-S, Wong C-H (2004) Dimeric aminoglycosides as antibiotics. Angew Chem Int Ed Engl 43:1562–1566
Altman S, Kirsebom LA (1999) Ribonuclease P. In: Gesteland R, Cech T, Atkins J (eds) RNA world II. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp 351–380
Ambrose V (2001) MicroRNAs: tiny regulators with great potential (minireview). Cell 107:823–826
Archibald S, Duong M (1984) Manganese acquisition by Lactobacillus plantarum. J Bacteriol 158:1–6
Ban N, Nissen P, Hansen J, Moore PB, Steitz TA (2000) The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution. Science 289:905–920
Begg EJ, Barclay ML (1995) Aminoglycosides—50 years on. Br J Clin Pharmacol 39:597–603
Berridge MJ, Bootman MD, Lipp P (1998) Calcium—a life and death signal. Nature 395:645–648
Brännvall M, Kirsebom LA (2001) Metal ion cooperativity in ribozyme cleavage of RNA. Proc Natl Acad Sci USA 98:12943–12947
Brännvall M, Mikkelesen NE, Kirsebom LA (2001) Monitoring the structure of Escherichia coli RNase P RNA in the presence of various metal ion. Nucleic Acids Res 29:1426–1432
Brännvall M, Kikovska E, Kirsebom LA (2004) Cross talk in RNase P RNA mediated cleavage. Nucleic Acids Res 32:5418–5429
Brodersen DE, Clemons WM Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (2000) The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103:1143–1154
Brown RS, Hingerty BE, Dewan JC, Klug A (1983) Pb(II)-catalysed cleavage of the sugar-phosphate backbone of yeast tRNAPhe—implications for lead toxicity and self-splicing RNA. Nature 303:543–546
Brown RS, Dewan JC, Klug A (1985) Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA. Biochemistry 24:4785–4801
Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V (2000) Functional insights from the structure of the 30S ribosomal subunit and its interaction with antibiotics. Nature 407:340–348
Cheng AC, Calabro V, Frankel AD (2001) Design of RNA-binding proteins and ligands. Curr Opin Struct Biol 11:478–484
Chia JS, Wu HL, Wang HW, Chen DS, Chen PJ (1997) Inhibition of hepatitis delta virus genomic ribozyme self-cleavage by aminoglycosides. J Biomed Sci 4:208–216
Corvaisier S, Bordeau V, Felden B (2002) Inhibition of transfer messenger RNA aminoacylation and trans-translation by aminoglycoside antibiotics. J Biol Chem 278:14788–14797
Davies J (1994) New pathogens and old resistance genes. Microbiologica 10:9–12
Davies J, Wright GD (1997) Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 5:234–240
Davies J, von Ahsen U, Schroeder R (1993) Antibiotics and the RNA world: a role for low-molecular-weight effectors in biochemical evolution? In: Gesteland RF, Atkins JF (eds) The RNA world. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 185–204
DeLano WL (2002) The PyMOL molecular graphics system on the World Wide Web: http://www.pymol.org. Cited 10 June 2005
Dessen A, Di Guilmi AM, Vernet T, Dideberg O (2001) Molecular mechanisms of antibiotic resistance in gram-positive pathogens. Curr Drug Targets Infect Disord 1:63–77
Earnshaw DJ, Gait MJ (1998) Hairpin ribozyme cleavage catalysed by aminoglycoside antibiotics and the polyamine spermine in the absence of metal ions. Nucleic Acids Res 26:5551–5561
Eubank TD, Biswas R, Jovanovic M, Litovchick A, Lapidot A, Gopalan V (2002) Inhibition of bacterial RNase P by aminoglycoside-arginine conjugates. FEBS Lett 511:107–112
Faber C, Sticht H, Schweimer K, Rösch P (2000) Structural rearrangements of HIV-1 Tatresponsive RNA upon binding of neomycin B. J Biol Chem 275:20660–20666
Fang XW, Yang XJ, Littrell K, Niranjanakumari S, Thiyagarajan P, Fierke CA, Sosnick TR, Pan T (2001) The Bacillus subtilis RNase P holoenzyme contains two RNase P RNA and two RNase P protein subunits. RNA 7:233–241
Fourmy D, Recht MI, Blanchard SC, Puglisi JD (1996) Structure of the A site of E. coli 16 S rRNA complexed with an aminoglycoside antibiotic. Science 274:1367–1371
Fourmy D, Recht MI, Puglisi JD (1998a) Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. J Mol Biol 277:347–362
Fourmy D, Yoshizawa S, Puglisi JD (1998b) Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J Mol Biol 277:333–345
Gegenheimer P, Apirion D (1981) Processing of prokaryotic ribonucleic acid. Microbiol Rev 45:502–541
Giegé R, Sissler M, Florentz C (1998) Universal rules and idiosyncratic features in tRNA identity. Nucleic Acids Res 26:5017–5035
Gottesman S (2004) The small RNA regulators of Escherichia coli: Roles and mechanisms. Annu Rev Microbiol 58:303–338
Griffey RH, Hofstadler SA, Sannes-Lowery KA, Ecker DJ, Crooke ST (1999) Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry. Proc Natl Acad Sci USA 96:10129–10133
Grundy FJ, Henkin TM (2004) Regulation of gene expression by effectors that bind to RNA. Curr Opin Microbiol 7:126–131
Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35:849–857
Hermann T (2003) Chemical and functional diversity of small molecule ligands for RNA. Biopolymers 70:4–18
Hermann T, Patel DJ (2000) Adaptive recognition by nucleic acid aptamers. Science 287:820–825
Hermann T, Westhof E (1998) Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA. J Mol Biol 276:903–912
Hermann T, Westhof E (1999) Docking of cationic antibiotics to negatively charged pockets in RNA folds. J Med Chem 42:1250–1251
Hershberg R, Altuvia S, Margalit H (2003) A survey of small RNA-encoding genes in Escherichia coli. Nucleic Acids Res 31:1813–1820
Hertweck M, Hiller R, Mueller MW (2002) Inhibition of nuclear pre-mRNA splicing by antibiotics in vitro. Eur J Biochem 269:175–183
Hsu M, Berg P (1978) Altering the specificity of restriction endonuclease: effect of replacing Mg2+ with Mn2+. Biochemistry 17:131–138
Huang C, Wolfgang MC, Withey J, Kommey M, Friedman DI (2000) Charged tmRNA but not tmRNA-mediated proteolysis is essential for Neisseria gonorrhoeae viability. EMBO J 19:1098–1107
Hutchin T, Cortopassi G (1994) Proposed molecular and cellular mechanism for aminoglycoside ototoxicity. Antimicrob Agents Chemother 38:2517–2520
Hyun Ryu D, Rando RR (2001) Aminoglycoside binding to human and bacterialA-site rRNA decoding region constructs. Bioorg Med Chem 9:2601–2608
Ikemura T, Dahlberg JE (1973) Small ribonucleic acids of Escherichia coli. II. Noncoordinate accumulation during stringent control. J Biol Chem 258:5033–5041
Jovine L (2003) Nuccyl http://www.mssm.edu/students/jovinl02/research/nuccyl.html.Cited 10 June 2005
Jovine L, Djordjevic S, Rhodes D (2000) The crystal structure of yeast phenylalanine tRNA at 2.0 Å resolution: cleavage by Mg2+ in 15-year-old crystals. J Mol Biol 301:401–414
Keiler KC, Waller PR, Sauer RT (1996) Role of tagging system in degradation of proteins synthesized from damaged messenger RNA. Science 271:990–993
Kirsebom LA, Virtanen A (2001) Inhibition of RNase P processing. In: Schroeder R, Wallis MG (eds) RNA-binding antibiotics. Molecular Biology Intelligence Unit 13, Eurekah.com, Austin. Landes Biosciences, Georgetown, pp 56–72
Kotra LP, Haddad J, Mobashery S (2000) Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother 44:3249–3256
Kovrigina E, Wesolowski D, Altman S (2003) Coordinate inhibition of expression of several genes for protein subunits of human nuclear RNase P. Proc Natl Acad Sci USA 100:1598–1602
Labuda D, Striker G, Porschke D (1984) Mechanism of codon recognition by transfer RNA and codon-induced tRNA association. J Mol Biol 174:587–604
Lazarus and Kitron (1973) Neomycin inhibition of DNA polymerase. Biochem Pharmacol 22:3115–3117
Litovchick A, Lapidot A, Eisenstein M, Kalinkovich A, Borkow G (2001) Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities. Biochemistry 40:15612–15623
Luedtke NW, Liu Q, Tor Y (2003) RNA-ligand interactions: affinity and specificity of aminoglycoside dimmers and acridine conjugates to the HIV-1 rev response element. Biochemistry 42:11391–11403
Mandal M, Boese B, Barrick JE, Winkler WC, Breaker RR (2003) Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 113:577–586
Mattick JS (2003) Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays 25:930–939
McDonald LJ, Mamrack MD (1995) Phosphoinositide hydrolysis by phospholipase C modulated by multivalent cations La(3+), Al(3+), neomycin, polyamines, and melittin. J Lipid Mediat Cell Signal 11:81–91
McManus MT (2004) Small RNAs and immunity. Immunity 21:747–756
Mei H-Y, Galan AA, Halim NS, Mack DP, Moreland DW, Sanders KB, Truong HN, Czarnik AW (1995) Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics. Bioorg Med Chem Lett 5:2755–2760
Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom LA (1999) Inhibition of RNase P RNA cleavage by aminoglycosides. Proc Natl Acad Sci USA 96:6155–6160
Mikkelsen NE, Johansson K, Virtanen A, Kirsebom LA (2001) Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complex. Nat Struct Biol 8:510–514
Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012
Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999) Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 43:727–737
Møller T, Franch T, Udesen C, Gerdes K, Valentin-Hansen P (2002) Spot 42 RNA mediates discoordinate expression of the E. coli galactose operon. Genes Dev 16:1696–1706
Nahvi A, Sudarsan N, Ebert MS, Zou X, Brown KL, Breaker RR (2002) Genetic control by a metabolite binding mRNA. Chem Biol 9:1043–1049
Nissen P, Hansen J, Ban N, Moore PB, Steitz TA (2000) The structural basis of ribosome activity in peptide bond synthesis. Science 289:920–930
Ogle JM, Brodersen DE, Clemons Jr WM, Tarry MJ, Carter AP, Ramakrishnan V (2001) Crystal structure of an initiation factor bound to the 30S ribosomal subunit. Science 292:897–902
Patel DJ, Suri AK, Jiang F, Jiang L, Fan P, Kumar RA, Nonin S (1997) Structure, recognition and adaptive binding in RNA aptamer complexes. J Mol Biol 272:645–664
Pedersen LC, Benning MM, Holden HM (1995) Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase. Biochemistry 34:13305–13311
Piolleti M, Schlünzen F, Harms J, Zarivach R, Glühmann M, Avila H, Bashan A, Bartels H, Auerbach T, Jacobi C, Hartsch T, Yonath A, Franceschi F (2001) Crystal structures of complexes of the small ribosomal subunits with tetracycline, edeine and IF3. EMBO J 20:1829–1839
Posey JE, Gherardini FC (2000) Lack of a role for iron in the Lyme disease pathogen. Science 288:1651–1653
Recht MI, Douthwaite S, Puglisi JD (1999) Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J 18:3133–3138
Ren Y-G, Martínez J, Kirsebom LA, Virtanen A (2002) Inhibition of Klenow DNA polymerase and poly(A)-specific ribonuclease by aminoglycosides. RNA 8:1393–1400
Rogers J, Chang AH, von Ahsen U, Schroeder R, Davies J (1996) Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. J Mol Biol 259:916–925
Sakon J, Liao HH, Kanikula AM, Benning MM, Rayment I, Holden HM (1993) Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-Å resolution. Biochemistry 32:11977–11984
Schlünzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F (2000) Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814–821
Schroeder R, Waldisch C, Wank H (2000) Modulation of RNA function by aminoglycoside antibiotics. EMBO J 19:1–9
Shi H, Moore PB (2000) The crystal structure of yeast phenylalanine tRNA at 1.93 Å resolution: a classic structure revisited. RNA 6:1091–1105
Stage TK, Hertel KJ, Uhlenbeck OC (1995) Inhibition of the hammerhead ribozyme by neomycin. RNA 1:95–101
Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135–138
Sucheck SJ, Shue YK (2001) Combinatorial synthesis of aminoglycoside libraries. Curr Opin Drug Discov Devel 4:462–470
Sullenger BA, Gilboa E (2002) Emerging clinical applications of RNA. Nature 418:252–258
Summers JS, Shimko J, Freedman FL, Badger CT, Sturgess M (2002) Displacement of Mn2+ fromRNA by K+, Mg2+, neomycin B, and an arginine-rich peptide: indirect detection of nucleic acid/ligand interactions using phosphorus relaxation enhancement. J Am Chem Soc 124:14934–149339
Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR (1985) Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother 27:495–498
Thompson J, Skeggs PA, Cundliffe E (1985)Methylationof 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer, Micromonospora purpurea. Mol Gen Genet 201:168–173
Tijsterman M, Ketting RF, Plasterk RH (2002) The genetics of RNA silencing. Annu Rev Genet 36:489–519
Uhlen P, Laestadius A, Jahnukainen T, Söderblom T, Backhed F, Celsi G, Brismar H, Normark S, Aperia A, Richter-Dahlfors A (2000) Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells. Nature 405:694–697
Van Bambeke F, Glupczynski Y, Plésiat P, Pechère JC, Tulkens PM (2003) Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother 51:1055–1065
Vicens Q, Westhof E (2001) Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure 9:647–658
Vicens Q, Westhof E (2002) Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding A site. Chem Biol 9:747–756
Vicens Q, Westhof E (2003a) RNA as a drug target: the case of aminoglycosides. Chembiochem 4:1018–1023
Vicens Q, Westhof E (2003b) Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J Mol Biol 326:1175–1188
Vioque A, Arnez J, Altman S (1988) Protein-RNA interactions in the RNase P holoenzyme from Escherichia coli. J Mol Biol 1988 202:835–848
Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS (2004) Riboswitches: the oldest mechanism for the regulation of gene expression? Trends Genet 20:44–50
Vogel J, Argaman L, Wagner EGH, Altuvia S (2005) The small RNA IstR inhibits synthesis of an SOS-induced toxic response. Curr Biol 14:2271–2276
von Ahsen U, Davies J, Schroeder R (1991) Antibiotic inhibition of group I ribozyme function. Nature 353:368–370
von Ahsen U, Davies J, Schroeder R (1992) Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics. J Mol Biol 226:935–941
Walsh C (2003) Antibiotics: actions, origins, resistance. ASM press, Washington DC
Walter F, Vicens Q, Westhof E (1999) Aminoglycoside-RNA interactions. Curr Opin Chem Biol 3:694–704
Walter F, Pütz J, Giegé R, Westhof E (2002) Binding of tobramycin leads to conformational changes in yeast tRNAAsp and inhibition of aminoacylation. EMBO J 21:760–768
Ward A, Campoli-Richards DM (1986) Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 32:425–444
Wassarman KM (2003) Diverse regulators of gene expression in response to environmental changes. Cell 109:141–144
Wassarman KM, Storz G (2000) 6S RNA regulates E. coli RNA polymerase activity. Cell 101:613–623
Winkler W, Nahvi A, Breaker RR (2002) Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 419:952–956
Withey JH, Friedman DI (2003) A salvage pathway for protein structures: tmRNA and trans-translation. Annu Rev Microbiol 57:101–123
Woegerbauer M, Burgmann H, Davies J, Graninger W (2000) DNase I induced DNA degradation is inhibited by neomycin. J Antibiot (Tokyo) 53:129–137
Yao S, Sgarbi PW, Marby KA, Rabuka D, O’Hare SM, Cheng ML, Bairi M, Hu C, Hwang S-B, Hwang C-K, Ichikawa Y, Sears P, Sucheck SJ (2004) Glyco-optimization of aminoglycosides: new aminoglycosides as novel anti-infective agents. Bioorg Med Chem Lett 14:3733–3738
Yonath A, Bashan A (2004) Ribosomal crystallography: initiation, peptide bond formation, and aminoacid polymerization are hampered by antibiotics. Annu Rev Microbiol 58:233–251
Zapp ML, Stern S, Green MR (1993) Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74:969–978
Zembower TR, Noskin GA, Postelnick MJ, Nguyen C, Peterson LR (1998) The utility of aminoglycosides in an era of emerging drug resistance. Int J Antimicrob Agents 10:95–105
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kirsebom, L., Virtanen, A., Mikkelsen, N. (2006). Aminoglycoside Interactions with RNAs and Nucleases. In: Erdmann, V., Barciszewski, J., Brosius, J. (eds) RNA Towards Medicine. Handbook of Experimental Pharmacology, vol 173. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27262-3_4
Download citation
DOI: https://doi.org/10.1007/3-540-27262-3_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-27261-8
Online ISBN: 978-3-540-27262-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)